Overview
- Major outlets reported Tuesday that the administration will not renew a temporary Part D subsidy program beyond 2026, a change first disclosed to the Wall Street Journal and picked up by Reuters and others.
- The program provided insurers about $3.6 billion this year to blunt premium increases for nearly 25 million standalone Part D enrollees and helped cut average plan premiums sharply in 2025–2026, according to MedPAC estimates.
- Administration officials told reporters they believe the subsidies encouraged insurers to raise rates and said roughly 25 percent of enrollees would see no increase or a decline, 30 percent would face under $10 more per month, and 45 percent would face $11–$20 higher monthly premiums.
- HHS and CMS had not issued a public comment when reporting first surfaced and beneficiaries are expected to learn new plan rates this fall, a timing that has prompted partisan criticism and heightened attention ahead of the midterm elections.
- Analysts and watchdogs warn the end of the subsidy could leave many seniors with higher out‑of‑pocket drug costs and prompt insurers to reprice plans, so watchers will be watching fall plan disclosures and further MedPAC analysis for concrete impacts.